Determination of the blood concentrations of cyanate after intravenous administration to patients with sickle-cell disease
Nigen, A.M.; Peterson, C.M.; Gillette, P.N.; Manning, J.M.
Journal of Laboratory and Clinical Medicine 83(1): 139-146
1974
ISSN/ISBN: 0022-2143 PMID: 4808651 Document Number: 78411
Document emailed within 1 workday
Related Documents
Dunston, T.; Rowland, R.; Huntsman, R.G.; Yawson, G. 1972: Sickle-cell haemolglobin C disease and sickle-cell beta thalassaemia in white South Africans South African Medical Journal 46(39): 1423-1426Shoda, Y.; Matsuyama, S.; Takarada, A.; Arai, M.; Nagashima, K.; Nakano, G.; Nakamura, T.; Kamisaka, K.; Matsuzawa, T.; Yoshino, T. 1986: Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases Japanese Journal of Antibiotics 39(5): 1259-1272
Cerami, A.; Manning, J.M.; Gillette, P.N.; De Furia, F.; Miller, D.; Graziano, J.H.; Peterson, C.M. 1973: Effect of cyanate on red blood cell sickling Federation Proceedings 32(6): 1668-1672
Rivera, J.P. 2000: Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit Annals of Neurology 47(2): 279-280
Oluboyede, O.A.; Ajayi, O.A.; Adeyokunnu, A.A. 1981: Iron studies in patients with sickle cell disease African Journal of Medicine and Medical Sciences 10(1-2): 1-7
Vichinsky, E.P. 2012: The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells Immunohematology 28(1): 20-23
Gross, M.L.; Schwedler, M.; Bischoff, R.J.; Kerstein, M.D. 1993: Impact of anesthetic agents on patients with sickle cell disease American Surgeon 59(4): 261-264
Vecchio, R.; Cacciola, E.; Murabito, P.; Gambelunghe, A.V.; Murabito, R.; Cacciola, R.R.; Di Martino, M. 2001: Laparoscopic cholecystectomy in adult patients with sickle cell disease Il Giornale di Chirurgia 22(1-2): 45-48
van Meurs, J.C. 1990: Vision-threatening eye manifestations in patients with sickle cell disease on Curaçao Nederlands Tijdschrift Voor Geneeskunde 134(37): 1800-1802
Cone, E.J.; Risner, M.E.; Neidert, G.L. 1978: Concentrations of phenethylamine in dog following single doses and during intravenous self-administration Research Communications in Chemical Pathology and Pharmacology 22(2): 211-232
Sassi, Fçal.; Bardi, R.; Neji, T.; Ayed, K.; Ben Dridi, M.Françoise. 2003: Immunological study in sickle cell disease patients: importance of the complement system La Tunisie Medicale 81(3): 195-199
Mehta, P. 1980: Significance of plasma beta-thromboglobulin values in patients with sickle cell disease Journal of Pediatrics 97(6): 941-944
Kotb, M.M.; Tantawi, W.H.; Elsayed, A.A.; Damanhouri, G.A.; Malibary, H.M. 2006: Brain MRi and CT findings in sickle cell disease patients from Western Saudi Arabia Neurosciences 11(1): 28-36
Fracasso, M.E.; Consolo, U.; Cuzzolin, L.; Ferronato, G.; Leone, R.; Benoni, G. 1989: Bone and soft tissue concentrations of aztreonam after intravenous administration Journal of ChemoTherapy 1(4 Suppl): 544-545
Larson, V.L.; Stowe, C.M. 1981: Plasma and tissue concentrations of oxytetracycline in the horse after intravenous administration American Journal of Veterinary Research 42(12): 2165-2166
Adetayo, F.O. 2009: Outcome of management of acute prolonged priapism in patients with homozygous sickle cell disease West African Journal of Medicine 28(4): 234-239
Comenzo, R.; Malachowski, M.; Berkman, E. 1992: Clinical correlation of positive direct antiglobulin tests in patients with sickle cell disease Immunohematology 8(1): 13-16
Horiuchi, K.; Onyike, A.E.; Osterhout, M.L. 1996: Sickling in vitro of reticulocytes from patients with sickle cell disease at venous oxygen tension Experimental Hematology 24(1): 68-76
De Graves, F.J.; Riddell, M.G.; Schumacher, J. 1996: Ketoprofen concentrations in plasma and milk after intravenous administration in dairy cattle American Journal of Veterinary Research 57(7): 1031-1033
Al-Samak, Z.M.; Al-Falaki, M.M.; Pasha, A.A. 2008: Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery Middle East Journal of Anaesthesiology 19(5): 983-995